Antioxidant Intervention to Improve Cognition in the Aging Brain: The Example of Hydroxytyrosol and Resveratrol

Int J Mol Sci. 2022 Dec 10;23(24):15674. doi: 10.3390/ijms232415674.

Abstract

Both physiological and pathological aging processes induce brain alterations especially affecting the speed of processing, working memory, conceptual reasoning and executive functions. Many therapeutic approaches to reduce the impact of brain aging on cognitive functioning have been tested; unfortunately, there are no satisfactory results as a single therapy. As aging is partly contributed by free radical reactions, it has been proposed that exogenous antioxidants could have a positive impact on both aging and its associated manifestations. The aim of this report is to provide a summary and a subsequent review of the literature evidence on the role of antioxidants in preventing and improving cognition in the aging brain. Manipulation of endogenous cellular defense mechanisms through nutritional antioxidants or pharmacological compounds represents an innovative approach to therapeutic intervention in diseases causing brain tissue damage, such as neurodegeneration. Coherently with this notion, antioxidants, especially those derived from the Mediterranean diet such as hydroxytyrosol and resveratrol, seem to be able to delay and modulate the cognitive brain aging processes and decrease the occurrence of its effects on the brain. The potential preventive activity of antioxidants should be evaluated in long-term exposure clinical trials, using preparations with high bioavailability, able to bypass the blood-brain barrier limitation, and that are well standardized.

Keywords: Mediterranean diet; aging; antioxidants; cognition; epigenetic; hydroxytyrosol; oxidative stress; resveratrol.

Publication types

  • Review

MeSH terms

  • Antioxidants* / metabolism
  • Antioxidants* / pharmacology
  • Antioxidants* / therapeutic use
  • Brain* / metabolism
  • Cognition
  • Oxidative Stress
  • Resveratrol / pharmacology
  • Resveratrol / therapeutic use

Substances

  • Antioxidants
  • Resveratrol
  • 3,4-dihydroxyphenylethanol

Grants and funding

This research received no external funding.